Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03971799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03971799
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-08
- Primary completion
- 2029-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.